Omnicell, Inc. revenue
Omnicell, Inc.'s revenue was $1.18bn in fiscal 2025, up 6.5% on the year before. Since fiscal 2009 ($213m) it has grown at a compound 11.3% a year. Over the last twelve months it was $1.25bn.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 213 | 222 | 246 | 314 | 381 | 441 | 485 | 696 | 713 | 787 | 897 | 892 | 1,132 | 1,296 | 1,147 | 1,112 | 1,185 | 1,247 |
| Growth on the year before | — | +4.2% | +10.4% | +27.9% | +21.2% | +15.8% | +9.9% | +43.6% | +2.4% | +10.5% | +13.9% | −0.5% | +26.9% | +14.5% | −11.5% | −3.0% | +6.5% | — |
| Gross profit | 105 | 118 | 136 | 171 | 203 | 234 | 248 | 317 | 319 | 372 | 437 | 413 | 555 | 589 | 497 | 471 | 503 | 558 |
| Gross margin | 49.3% | 53.0% | 55.3% | 54.3% | 53.4% | 53.0% | 51.2% | 45.6% | 44.7% | 47.3% | 48.7% | 46.3% | 49.0% | 45.4% | 43.3% | 42.3% | 42.5% | 44.8% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Products | $666M | 56.2% | ▲ 5.6% |
| Connected Devices Software Licenses and Other (part of Products) | $565M | 84.9% | ▲ 4.9% |
| Consumables (part of Products) | $100M | 15.1% | ▲ 9.7% |
| Services | $519M | 43.8% | ▲ 7.8% |
| Technical Services (part of Services) | $260M | 50.1% | ▲ 9.2% |
| Saa S and Expert Services (part of Services) | $259M | 49.9% | ▲ 6.4% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $1.1B | 89.9% | ▲ 5.2% |
| Outside the US | $120M | 10.1% | ▲ 19.9% |
From Omnicell, Inc.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Omnicell, Inc. | $1.25bn | 8.5% | 0.3% |
| Waystar Holding Corp. | $1.26bn | 21.4% | — |
| Tempus AI, Inc. | $1.51bn | 36.6% | — |
| Goodrx Holdings, Inc. | $785m | -1.8% | 1.8% |
| Doximity, Inc. | $656m | 11.2% | 14.5% |
| Teladoc Health, Inc. | $2.47bn | -2.4% | -1.5% |
Compare with peers
- Waystar Holding Corp. revenue
- Tempus AI, Inc. revenue
- Goodrx Holdings, Inc. revenue
- Doximity, Inc. revenue
- Teladoc Health, Inc. revenue
Head to head: OMCL vs WAYOMCL vs TEMGDRX vs OMCL
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies